What Are Obesogens? Chemicals That Promote Fat Storage

Obesogens are environmental chemicals that can promote fat gain through mechanisms that have nothing to do with how much you eat or exercise. The term, coined in 2006, describes a growing list of synthetic and naturally occurring compounds found in plastics, pesticides, food packaging, personal care products, and household goods. These chemicals act on hormonal pathways, fat cell development, metabolism, and even gut bacteria in ways that tilt the body toward storing more fat. The idea remains somewhat controversial in terms of how much it contributes to the global obesity epidemic, but a 2023 expert workshop concluded that environmental obesogens are “real, significant, and a contributor at some degree to weight gain at the individual level and to the global obesity and metabolic disease pandemic at a societal level.”¹

How Obesogens Promote Fat Storage

The obesogen hypothesis proposes that certain chemicals increase the body’s tendency to create and enlarge fat cells, shift metabolic set points, or alter hormonal signals that control appetite and satiety.² The best-understood pathway involves a receptor inside cells called PPARγ, which is essentially a master switch for turning stem cells into fat cells. When PPARγ gets activated at the wrong time or by the wrong signal, the body produces more fat cells than it otherwise would.

The chemical tributyltin (TBT), once widely used in marine antifouling paints, was the first obesogen for which researchers worked out a clear mechanism. TBT binds to both PPARγ and a partner receptor called RXR at extremely low concentrations, flipping on the fat-cell creation machinery.³ When pregnant mice are exposed to TBT, their offspring are born with more fat in their fat depots, liver, and other tissues, and they carry more body fat into adulthood.⁴ TBT also produces a subtly different kind of fat cell: one with lower levels of adiponectin (a hormone that improves insulin sensitivity) and altered glucose handling, which could compound metabolic problems beyond simple fat gain.⁵

PPARγ is not the only target. Some obesogens act through glucocorticoid receptors, estrogen receptors, or thyroid hormone pathways. The flame retardant TBBPA, for example, drives fat accumulation by triggering PPARγ, glucocorticoid receptor signaling, and a nontraditional estrogen receptor network simultaneously.⁶ Several pesticides interfere with thyroid hormone production and metabolism, which can slow the metabolic rate and promote weight gain indirectly.⁷ The range of receptor targets helps explain why so many structurally different chemicals can all nudge the body in the same direction.

Which Chemicals Are Considered Obesogens

The candidate list has grown substantially since the early focus on TBT. It now includes chemicals most people encounter daily. Here are the major categories, along with what the evidence shows for each.

Bisphenol A

BPA lines the inside of food and beverage cans, coats thermal receipt paper, and shows up in many hard polycarbonate plastics. In a large cross-sectional analysis of U.S. adults, those in the highest quartile of urinary BPA had roughly 1.8 times the odds of obesity compared with those in the lowest quartile. The “BPA-free” substitutes BPF and BPS did not show the same association in that study.⁸ A broader review of epidemiological studies using biomonitoring confirmed dose-dependent positive associations between BPA and various obesity measures, making it one of the most consistently linked chemicals.⁹

Phthalates

Phthalates soften plastics and stabilize fragrances. They are in vinyl flooring, food packaging, cosmetics, and medical tubing. The metabolic concern with phthalates centers less on direct fat-cell creation and more on insulin resistance. In a study of U.S. adolescents, higher urinary levels of DEHP metabolites were linked to greater insulin resistance; the most-exposed third of teens had about a 50% higher prevalence of insulin resistance compared to the least-exposed third.¹⁰ In adults, DEHP metabolites were associated with higher fasting glucose, higher insulin, and worse blood sugar control.¹¹ Animal work has traced one mechanism: DEHP generates oxidative stress in fat tissue, disrupting insulin signaling and reducing glucose uptake into cells.¹² That said, the epidemiological picture for phthalates and obesity itself is mixed. Some phthalate metabolites show associations with obesity in specific age groups while others do not.¹³

PFAS

Per- and polyfluoroalkyl substances, the “forever chemicals” used in nonstick coatings, waterproof clothing, and food packaging, have drawn increasing attention as obesogens. One of the most striking findings comes from a weight-loss trial: participants who started with higher blood levels of PFAS regained more weight after dieting, and their resting metabolic rate recovered more slowly during regain, especially among women.¹⁴ A study of adolescents who underwent bariatric surgery found that those with higher concentrations of certain PFAS compounds regained more weight and waist circumference over the five years following surgery.¹⁵ PFAS compounds are also among the persistent organic pollutants linked to disrupted thyroid hormone levels in mothers and infants, which could compound their metabolic effects.¹⁶

Pesticides and Heavy Metals

DDE, the persistent breakdown product of the banned pesticide DDT, and PFOA (a legacy PFAS compound) have shown the most consistent positive associations with obesity in human biomonitoring studies of persistent organic pollutants.¹⁷ Heavy metals also appear to play a role. An analysis of U.S. adults using NHANES data found that cumulative heavy metal exposure was independently associated with higher BMI, greater skinfold thickness, and more total body fat.¹⁸

How Obesogens Mess With Appetite Signals

Fat-cell creation is only part of the picture. Some obesogens appear to interfere with the brain circuits that regulate hunger and fullness. The hypothalamus houses neurons that balance energy intake and expenditure, and several chemicals disrupt that balance. TBT, for instance, increases the firing rate of leptin-receptor neurons in the dorsomedial hypothalamus of mice, which could distort the brain’s reading of how much fat the body is carrying.¹⁹

BPA takes a different and somewhat paradoxical approach: in hypothalamic neuron cell lines, it simultaneously boosts the expression of both appetite-stimulating and appetite-suppressing signals. That sounds like it would cancel out, but the net effect seems to be dysregulation rather than balance. When conflicting inputs flood the system, the normal feedback loop breaks down, potentially pushing energy intake and expenditure out of alignment.²⁰

The Gut Microbiome Connection

An emerging line of research suggests that some obesogens promote fat gain partly by reshaping the community of microbes in the gut. People with high chemical exposure show shifts in the abundance of numerous bacterial species and altered levels of bile acids that influence fat storage and insulin sensitivity.²¹ Causal inference modeling in that study pointed to microbiome-derived bile acids as a possible link between the chemical exposure and the metabolic outcomes.

Triclosan, the antibacterial compound once ubiquitous in hand soaps and toothpaste, provides one of the cleaner demonstrations. In rats, triclosan reduced gut microbial diversity and lowered levels of butyrate, a short-chain fatty acid that supports a healthy gut lining and normal metabolism. The researchers showed the effect was genuinely microbiome-driven: transplanting gut bacteria from unexposed control rats, or simply supplementing butyrate, reversed the metabolic damage triclosan had caused.²²

Prenatal Exposure and Transgenerational Effects

The timing of exposure matters enormously. Disruption during fetal development or early infancy can reprogram how the body handles fat for life, because that is when stem cells are deciding their fate and metabolic set points are being established.²³ In mice, prenatal TBT exposure biases multipotent stem cells toward becoming fat cells rather than bone or other tissue types, and this bias persists in stem cells harvested from adult animals long after the chemical exposure ended.²⁴

Perhaps the most unsettling finding is that obesogen effects can be inherited across generations that were never directly exposed. In animal models, the metabolic consequences of TBT exposure have been traced through at least the fourth generation, transmitted through epigenetic changes rather than alterations to the DNA sequence itself.²⁵ Metabolomic profiling has confirmed these transgenerational effects, though they show up differently by sex: male descendants tend to become obese, while female descendants show distinct metabolic fingerprints consistent with impaired liver detoxification capacity rather than overt obesity.²⁶

Sex Differences in Obesogen Responses

The sex-specific pattern extends beyond transgenerational studies. In the PFAS weight-loss trial mentioned earlier, the association between PFAS levels and weight regain was stronger in women than men.²⁷ In contrast, the transgenerational TBT studies in mice find that obesity itself shows up primarily in males, while females show subtler metabolic changes.²⁸ Gut microbiome responses to chemical exposure also differ by sex, with males showing increased abundance of several bacterial species while females showed a decrease in one key species.²⁹

These differences probably reflect the interaction between obesogens and sex hormones. Many obesogens act through estrogen or androgen receptor pathways, so the hormonal environment of the exposed individual shapes the downstream effect. This means findings from one sex in animal or human studies do not automatically apply to the other, a detail that complicates risk assessment and partly explains why some studies find associations in women but not men, or vice versa.

How Strong Is the Human Evidence

The animal evidence for obesogens is extensive and mechanistically detailed. The human evidence is more uneven. Cross-sectional studies consistently find associations between chemical exposure levels and obesity or metabolic markers, but cross-sectional data cannot prove causation. You cannot rule out reverse causality: people with more body fat store more fat-soluble chemicals, so higher chemical levels in heavier people could partly reflect their body composition rather than cause it.

The most persuasive human data comes from prospective studies and those examining prenatal exposure. The PFAS weight-regain findings are prospective, meaning chemical levels were measured before the weight changes happened, which makes reverse causation less likely.³⁰ Mixture analyses in large population surveys have also identified specific chemical exposure patterns associated with obesity even after adjusting for diet, physical activity, and socioeconomic factors.³¹ Still, the expert consensus at this point is that obesogens are a genuine contributing factor, not that they are the primary driver of the obesity epidemic. Diet, physical activity, sleep, and genetics remain the dominant players. Obesogens may help explain why some people seem to gain weight more easily than others despite similar habits, and why population-level obesity has risen so steeply in recent decades even in places where caloric intake has not changed dramatically.

Food Additives as Possible Obesogens

The obesogen conversation has recently expanded beyond industrial chemicals to include common food additives. Dietary emulsifiers like carboxymethylcellulose and polysorbate 80, found in ice cream, salad dressings, baked goods, and many processed foods, can shift gut bacteria toward a pro-inflammatory profile linked to metabolic problems. Mouse studies showed that even relatively low levels of these emulsifiers led to low-grade inflammation and the development of obesity and metabolic syndrome.³² A review of the broader literature supported the hypothesis that widespread emulsifier use could be contributing to rising rates of obesity and chronic inflammatory disease, though the evidence is still largely from animal models.³³ Whether the doses humans consume through processed food are sufficient to produce the same effects seen in lab animals remains an open question. The research is worth watching, though, because unlike industrial pollutants, food additives represent an exposure route that consumers and regulators could address relatively quickly.

Reducing Your Exposure

You cannot eliminate obesogen exposure entirely. These chemicals are too pervasive for that. But you can meaningfully reduce the most concentrated sources:

Food contact: Avoid heating food in plastic containers or wrapping. Use glass or stainless steel for storage. Minimize canned food, which often has BPA or substitutes in the lining.
Personal care products: Check labels for phthalates (sometimes listed as “fragrance”) and triclosan. Simpler formulations tend to carry fewer endocrine disruptors.
Water filtration: Activated carbon or reverse osmosis filters can reduce PFAS and certain pesticide residues in drinking water.
Dust control: Flame retardants and phthalates accumulate in household dust. Regular vacuuming with a HEPA filter and wet dusting helps.
Diet quality: Diets rich in fruits, vegetables, and bioactive nutrients with antioxidant and anti-inflammatory properties may reduce the body’s vulnerability to the metabolic damage caused by persistent organic pollutants.³⁴

These steps are not a cure for chemical exposure you have already experienced, particularly prenatal exposure, which by definition happened before you had any control over it. They are about reducing ongoing exposure and supporting the body’s capacity to handle the chemicals it encounters.

Gaps in Regulation and Testing

One reason the obesogen problem persists is that chemical safety testing was not designed to look for metabolic disruption. Standard toxicology tests focus on acute poisoning, cancer, and reproductive harm. They rarely measure things like fat tissue distribution, adiponectin levels, or insulin resistance, the very endpoints that would reveal an obesogen. A 2025 review evaluated how current OECD test guidelines could be updated to better capture these effects, recommending the inclusion of hormone measurements like leptin, resistin, and adiponectin, along with assessment of fatty tissue distribution and insulin sensitivity in test animals.³⁵

There is also a dose problem. Many obesogens act at extremely low concentrations, sometimes in the nanomolar range, which is far below the thresholds used in traditional toxicology. The fungicide triflumizole, for example, triggers fat-cell development in stem cells at low nanomolar levels and increases fat depot weight in mice exposed prenatally.³⁶ Classic toxicology assumes “the dose makes the poison” in a straightforward way, but endocrine disruptors often show non-monotonic dose responses, meaning a lower dose can sometimes produce a larger effect than a higher one. This makes conventional threshold-based regulation poorly suited to catching obesogens before they reach consumers. Until testing protocols catch up to the biology, many chemicals with obesogenic potential will continue to enter commerce without the relevant metabolic endpoints ever being measured.

1
PubMed Central. Obesogens and Obesity: State-of-the-Science and Future Directions Summary from a Healthy Environment and Endocrine Disruptors Strategies Workshop ↩︎
2
PubMed Central. Environmental Obesogens: Mechanisms and Controversies ↩︎
3
PubMed Central. Minireview: PPARγ as the target of obesogens ↩︎
4
Molecular Endocrinology. Endocrine-Disrupting Organotin Compounds Are Potent Inducers of Adipogenesis in Vertebrates ↩︎
5
PubMed Central. Tributyltin Differentially Promotes Development of a Phenotypically Distinct Adipocyte ↩︎
6
PubMed Central. Environmental Obesogens and Their Perturbations in Lipid Metabolism ↩︎
7
PubMed Central. Pesticides With Potential Thyroid Hormone-Disrupting Effects: A Review of Recent Data ↩︎
8
PubMed Central. Bisphenol A substitutes and obesity in US adults: analysis of a population-based, cross-sectional study ↩︎
9
PubMed Central. Life-Time Environmental Chemical Exposure and Obesity: Review of Epidemiological Studies Using Human Biomonitoring Methods ↩︎
10
PubMed Central. Urinary phthalates and increased insulin resistance in adolescents ↩︎
11
Science of The Total Environment. The associations between phthalate exposure and insulin resistance, β-cell function and blood glucose control in a population-based sample ↩︎
12
Journal of Cellular Biochemistry. Phthalate is associated with insulin resistance in adipose tissue of male rat: role of antioxidant vitamins ↩︎
13
PubMed Central. Life-Time Environmental Chemical Exposure and Obesity: Review of Epidemiological Studies Using Human Biomonitoring Methods ↩︎
14
PubMed Central. Perfluoroalkyl substances and changes in body weight and resting metabolic rate in response to weight-loss diets: A prospective study ↩︎
15
PubMed Central. PFAS Exposure and Postoperative Weight Regain in Adolescents After Bariatric Surgery: Findings From the Teen‐LABS Study ↩︎
16
PubMed Central. Persistent Organic Pollutants and the Association with Maternal and Infant Thyroid Homeostasis: A Multipollutant Assessment ↩︎
17
PubMed Central. Life-Time Environmental Chemical Exposure and Obesity: Review of Epidemiological Studies Using Human Biomonitoring Methods ↩︎
18
PubMed Central. Associations of cumulative exposure to heavy metal mixtures with obesity and its comorbidities among U.S. adults in NHANES 2003-2014 ↩︎
19
Environmental Pollution. Effects of endocrine disruptors on the electrical activity of leptin receptor neurons in the dorsomedial hypothalamus and anxiety-like behavior in male mice ↩︎
20
Neuroendocrinology. Obesogens and Energy Homeostasis: Definition, Mechanisms of Action, Exposure, and Adverse Effects on Human Health ↩︎
21
Environment International. Exposure to environmental toxicants is associated with gut microbiome dysbiosis, insulin resistance and obesity ↩︎
22
Ecotoxicology and Environmental Safety. Triclosan induced obesity via gut microbiota dysbiosis and butyrate reduction ↩︎
23
PubMed. Perturbed nuclear receptor signaling by environmental obesogens as emerging factors in the obesity crisis ↩︎
24
Molecular Endocrinology. Prenatal Exposure to the Environmental Obesogen Tributyltin Predisposes Multipotent Stem Cells to Become Adipocytes ↩︎
25
PubMed Central. Epigenetic Transgenerational Inheritance of the Effects of Obesogen Exposure ↩︎
26
PubMed Central. Transgenerational metabolomic fingerprints in mice ancestrally exposed to the obesogen TBT ↩︎
27
PubMed Central. Perfluoroalkyl substances and changes in body weight and resting metabolic rate in response to weight-loss diets: A prospective study ↩︎
28
PubMed Central. Transgenerational metabolomic fingerprints in mice ancestrally exposed to the obesogen TBT ↩︎
29
Environment International. Exposure to environmental toxicants is associated with gut microbiome dysbiosis, insulin resistance and obesity ↩︎
30
PubMed Central. Perfluoroalkyl substances and changes in body weight and resting metabolic rate in response to weight-loss diets: A prospective study ↩︎
31
PubMed Central. Chemical mixture exposure patterns and obesity among U.S. adults in NHANES 2005-2012 ↩︎
32
PubMed Central. Food Additives’ Impact on Gut Microbiota and Metabolic Syndrome: A Systematic Review ↩︎
33
PubMed Central. Food Emulsifiers and Metabolic Syndrome: The Role of the Gut Microbiota ↩︎
34
PubMed Central. Modulation of persistent organic pollutant toxicity through nutritional intervention: emerging opportunities in biomedicine and environmental remediation ↩︎
35
Regulatory Toxicology and Pharmacology. Towards EU regulatory hazard assessment of metabolic endocrine disrupters: Integrating new biomarkers into OECD test guidelines ↩︎
36
PubMed Central. Triflumizole is an obesogen in mice that acts through peroxisome proliferator activated receptor gamma (PPARγ) ↩︎